TY - JOUR T1 - Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation JO - Health Technology Assessment UR - https://eprints.whiterose.ac.uk/id/eprint/162546 PY - 2020/06/01 AU - Davis S AU - Simpson E AU - Hamilton J AU - James MM-S AU - Rawdin A AU - Wong R AU - Goka E AU - Gittoes N AU - Selby P ED - DO - DOI: 10.3310/hta24290 PB - National Institute for Health Research VL - 24 IS - 29 Y2 - 2025/05/22 ER -